Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Regulators Associated With N6-Methyladenosine in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma Reveal New Clinical and Prognostic Markers
Shuzhen Tan, Zesong Li, Kai Li, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 9

Showing 9 citing articles:

The effect of N6-methyladenosine (m6A) factors on the development of acute respiratory distress syndrome in the mouse model
Liming Fei, Gengyun Sun, Juan Sun, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 7622-7634
Open Access | Times Cited: 32
The critical roles of m6A RNA methylation in lung cancer: from mechanism to prognosis and therapy
Mei-Ning Diao, Xiao‐Jing Zhang, Yinfeng Zhang
British Journal of Cancer (2023) Vol. 129, Iss. 1, pp. 8-23
Open Access | Times Cited: 18
Risk score = LncRNAs associated with doxorubicin metabolism can be used as molecular markers for immune microenvironment and immunotherapy in non-small cell lung cancer
Qianyi Lin, Ming Zhang, Ying Kong, et al.
Heliyon (2023) Vol. 9, Iss. 3, pp. e13811-e13811
Open Access | Times Cited: 12
Identified Gefitinib Metabolism-Related lncRNAs can be Applied to Predict Prognosis, Tumor Microenvironment, and Drug Sensitivity in Non-Small Cell Lung Cancer
Weilong Ye, Zhengguo Wu, Pengbo Gao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
Prognostic model and immunotherapy prediction based on molecular chaperone-related lncRNAs in lung adenocarcinoma
Yue Xu, Tao Tao, Yong Li, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 11
Comprehensive assessment of base excision repair (BER)-related lncRNAs as prognostic and functional biomarkers in lung adenocarcinoma: implications for personalized therapeutics and immunomodulation
Junzheng Zhang, Lu Song, Guanrong Li, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 19, pp. 17199-17213
Closed Access | Times Cited: 6
Predicting pan-cancer immune-checkpoint therapy and prognosis with a chromatin-accessibility-related alternative splicing signature: a retrospective study
Yitong Li, Feifei Lan, Yi‐Ling Lin, et al.
International Journal of Surgery Oncology (2024)
Open Access
Development and application of a predictive model for survival and drug therapy based on COVID-19-related lncRNAs in non-small cell lung cancer
Ziyuan Huang, Zenglei Han, Kairong Zheng, et al.
Medicine (2024) Vol. 103, Iss. 49, pp. e40629-e40629
Open Access
Editorial: Epigenetics in Cancer: Mechanisms and Drug Development
Huiqing Yuan, Yongmei Huang, Susu Tao, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access
Page 1

Scroll to top